speb/financial-data huggingface dataset:
Financial ratios for ALECO.PA — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 7287198.888888889
Buffett classification: The Gruesome
Stock price: 2.833333333333333
Shares outstanding: 5439693
Book value: 7590567.777777778
P/B ratio: 2.030475710278443
Market cap (USD): 15412463.499999998
Debt to equity: 0.2969032765957634
Current ratio: 2.8309723435384395
Quick ratio: 1.899160365798175
Buyback yield (%): 0
Retained earnings: -3539802.222222222
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALECO.PA — annual report dated 2024-09-30
Total revenue: 44855286.666666664
Gross profit: 17349757.777777776
Operating income: -3945986.6666666665
Net income: -3539802.222222222
Capital expenditures: 32586.666666666664
Operating cash flow: -3873988.888888889
Depreciation & amortization: 773887.7777777778
Net tangible assets: 7287198.888888889
Owner earnings: -2798501.1111111105
Return on net tangible assets (%): -38.40297422618872
Buffett classification: The Gruesome
Stock price: 2.833333333333333
Shares outstanding: 5439693
Book value: 7590567.777777778
P/B ratio: 2.030475710278443
Market cap (USD): 15412463.499999998
Debt to equity: 0.2969032765957634
Current ratio: 2.8309723435384395
Quick ratio: 1.899160365798175
Interest coverage ratio: -48.0612236612399
COGS to revenue (%): 61.32059548139972
SG&A to revenue (%): 24.515190306565625
Free cash flow (dilution-adjusted): -4271610
Buyback yield (%): 0
Retained earnings: -3539802.222222222
Inventory turnover: 7.625768623081503
Receivables turnover: 57.26361135973877
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -38.0840833859153
FCF margin (%): -9.5230915181607
Revenue growth (%): 2.84140755110351
Rule of 40 score: -6.6816839670571895
Financial ratios for ALECO.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 5764905.434782608
Buffett classification: The Gruesome
Stock price: 3.0652173913043477
Shares outstanding: 5439693
Book value: 6037093.47826087
P/B ratio: 2.761898858614298
Market cap (USD): 16673841.586956521
Debt to equity: 0.3034302786793097
Current ratio: 2.0681988745168525
Quick ratio: 1.0979332463962215
Buyback yield (%): 0
Retained earnings: -1385907.608695652
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALECO.PA — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 3577752.941176471
Buffett classification: The Gruesome
Stock price: 2.4705882352941178
Shares outstanding: 5439693
Book value: 3826097.647058822
P/B ratio: 3.512519221704315
Market cap (USD): 13439241.529411765
Debt to equity: 0.846887459900012
Current ratio: 2.1026965867549947
Quick ratio: 1.2049256924198428
Buyback yield (%): 0
Retained earnings: -4195405.882352942
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALECO.PA — annual report dated 2025-09-30
Total revenue: 45944591.76470588
Gross profit: 18287661.17647059
Operating income: -3117916.470588235
Net income: -4195405.882352942
Capital expenditures: 310124.70588235295
Operating cash flow: -3088341.1764705884
Depreciation & amortization: 687114.1176470588
Net tangible assets: 3577752.941176471
Owner earnings: -3818416.4705882357
Return on net tangible assets (%): -106.726667083184
Buffett classification: The Gruesome
Stock price: 2.4705882352941178
Shares outstanding: 5439693
Book value: 3826097.647058822
P/B ratio: 3.512519221704315
Market cap (USD): 13439241.529411765
Debt to equity: 0.846887459900012
Current ratio: 2.1026965867549947
Quick ratio: 1.2049256924198428
Interest coverage ratio: -49.59539270542882
COGS to revenue (%): 60.196270172283995
SG&A to revenue (%): 26.553874880953153
Free cash flow (dilution-adjusted): -3454290.588235294
Buyback yield (%): 0
Retained earnings: -4195405.882352942
Inventory turnover: 6.37558739559634
Receivables turnover: 47.78802904023563
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -39.97416233085037
FCF margin (%): -7.518383460507404
Revenue growth (%): 2.4284876521560905
Rule of 40 score: -5.089895808351313
Financial ratios for AMG.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 196.04545454545456
Shares outstanding: 539708274
Market cap (USD): 105807353898.27274
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMG.DE — annual report dated 2022-12-31
Total revenue: 26323000000
Gross profit: 19917000000
Operating income: 9566000000
Net income: 6552000000
Capital expenditures: 936000000
Operating cash flow: 9721000000
Depreciation & amortization: 3417000000
Net tangible assets: -27948000000
Owner earnings: 9033000000
Return on net tangible assets (%): -32.320738514383855
Capex to operating income (%): 9.784653982855948
Buffett classification: The Great
Stock price: 232.10638297872342
P/E ratio: 19.11931247585925
Shares outstanding: 539708274
Book value: 3661000000
P/B ratio: 34.217354641308326
Market cap (USD): 125269735341.82979
Debt to equity: 10.63780387872166
Current ratio: 1.414292088990884
Quick ratio: 1.1000191241155097
Effective tax rate (%): 10.80860332153553
Interest coverage ratio: 6.803698435277383
COGS to revenue (%): 24.33613189985944
R&D to revenue (%): 16.844584583824034
SG&A to revenue (%): 20.567564487330472
Free cash flow (dilution-adjusted): 8384000000
Buyback yield (%): 5.077044333689338
Retained earnings: -28622000000
Inventory turnover: 1.2993914807302231
Receivables turnover: 4.118116395494368
Capitalized R&D asset: 4434000000
ROCI (R&D-adjusted, %): 23.24571173980842
FCF margin (%): 31.85047297040611
Rule of 40 score: 31.85047297040611
Financial ratios for AMG.DE — annual report dated 2023-12-31
Total revenue: 28190000000
Gross profit: 19739000000
Operating income: 7897000000
Net income: 6717000000
Capital expenditures: 1112000000
Operating cash flow: 8471000000
Depreciation & amortization: 4071000000
Net tangible assets: -45038000000
Owner earnings: 9676000000
Return on net tangible assets (%): -21.484080110129224
Capex to operating income (%): 14.081296694947449
Buffett classification: The Great
Stock price: 265.75555555555553
P/E ratio: 21.353353013964565
Shares outstanding: 539708274
Book value: 6232000000
P/B ratio: 23.015159209691912
Market cap (USD): 143430472194.8
Debt to equity: 10.367939666238767
Current ratio: 1.64919530230535
Quick ratio: 1.1316876903001305
Effective tax rate (%): 14.487587523870147
Interest coverage ratio: 2.746782608695652
COGS to revenue (%): 29.978715856686765
R&D to revenue (%): 16.970556935083366
SG&A to revenue (%): 21.91912025540972
Free cash flow (dilution-adjusted): 6928000000
Buyback yield (%): 0
Retained earnings: -26549000000
Inventory turnover: 0.8878966169363312
Receivables turnover: 3.5494837572399898
Capitalized R&D asset: 7754780000
ROCI (R&D-adjusted, %): 11.1057454211002
Rosenberg metric: -0.040144339197113216
FCF margin (%): 24.576090812344802
Revenue growth (%): 7.092656612088288
Rule of 40 score: 31.66874742443309
Financial ratios for AMG.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 301.76666666666665
Shares outstanding: 539708274
Market cap (USD): 162865966817.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMG.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 247.86458333333334
Shares outstanding: 539708274
Market cap (USD): 133774566456.5625
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMG.DE — annual report dated 2024-12-31
Total revenue: 33424000000
Gross profit: 20566000000
Operating income: 7258000000
Net income: 4090000000
Capital expenditures: 1096000000
Operating cash flow: 11490000000
Depreciation & amortization: 5592000000
Net tangible assets: -40459000000
Owner earnings: 8586000000
Return on net tangible assets (%): -21.221483477100275
Capex to operating income (%): 15.100578671810416
Buffett classification: The Great
Stock price: 247.86458333333334
P/E ratio: 32.70771796003974
Shares outstanding: 539708274
Book value: 5877000000
P/B ratio: 22.762390072581674
Market cap (USD): 133774566456.5625
Debt to equity: 10.226135783563043
Current ratio: 1.256764362093597
Quick ratio: 0.953807524135244
Effective tax rate (%): 11.26057713169885
Interest coverage ratio: 2.300475435816165
COGS to revenue (%): 38.46936333173767
R&D to revenue (%): 17.843465773097176
SG&A to revenue (%): 21.230253709909046
Free cash flow (dilution-adjusted): 9864000000
Buyback yield (%): 0.14950524998706788
Retained earnings: -27590000000
Inventory turnover: 1.8373821091740496
Receivables turnover: 4.928339722795635
Capitalized R&D asset: 10632500000
ROCI (R&D-adjusted, %): 10.2823186032106
Rosenberg metric: 0.17286789297658864
FCF margin (%): 29.511728099569172
Revenue growth (%): 18.566867683575737
Rule of 40 score: 48.078595783144905
Financial ratios for AMG.DE — quarterly report dated 2025-03-31
Total revenue: 8149000000
Gross profit: 5181000000
Operating income: 1178000000
Net income: 1730000000
Capital expenditures: 411000000
Operating cash flow: 1391000000
Depreciation & amortization: 1387000000
Net tangible assets: -38162000000
Owner earnings: 2706000000
Return on net tangible assets (%): -7.090823332110477
Capex to operating income (%): 34.88964346349746
Buffett classification: The Good
Stock price: 300.6521739130435
P/E ratio: 23.44862223366424
Shares outstanding: 539708274
Book value: 6207000000
P/B ratio: 26.142172685187134
Market cap (USD): 162264465856.95654
Debt to equity: 9.24456259062349
Current ratio: 1.1704189847009736
Quick ratio: 0.8779554937413073
Effective tax rate (%): 12.316269640141916
Interest coverage ratio: 1.6293222683264177
COGS to revenue (%): 36.42164682783164
R&D to revenue (%): 18.235366302613816
SG&A to revenue (%): 20.70192661676279
Free cash flow (dilution-adjusted): 895000000
Buyback yield (%): 0
Retained earnings: -27140000000
Inventory turnover: 0.4410759399613613
Receivables turnover: 1.0020905066404329
Capitalized R&D asset: 1486000000
ROCI (R&D-adjusted, %): 3.196501830152062
FCF margin (%): 10.98294269235489
Rule of 40 score: 10.98294269235489
Financial ratios for AMG.DE — quarterly report dated 2025-06-30
Total revenue: 9179000000
Gross profit: 6168000000
Operating income: 2656000000
Net income: 1432000000
Capital expenditures: 369000000
Operating cash flow: 2280000000
Depreciation & amortization: 1341000000
Net tangible assets: -35860000000
Owner earnings: 2404000000
Return on net tangible assets (%): -6.703848298940324
Capex to operating income (%): 13.893072289156628
Buffett classification: The Great
Stock price: 270.3764705882353
P/E ratio: 46.14940489291216
Shares outstanding: 539708274
Book value: 7428000000
P/B ratio: 19.64518285829136
Market cap (USD): 145924418271.38824
Debt to equity: 7.566505115778137
Current ratio: 1.305626098847431
Quick ratio: 0.9841277593279938
Effective tax rate (%): 8.673469387755102
Interest coverage ratio: 3.8270893371757926
COGS to revenue (%): 32.80313759668809
R&D to revenue (%): 18.999891055670552
SG&A to revenue (%): 18.422486109597997
Free cash flow (dilution-adjusted): 1754000000
Buyback yield (%): 0
Retained earnings: -25708000000
Inventory turnover: 0.4573902476074738
Receivables turnover: 1.0549362142282497
Capitalized R&D asset: 2739620000
ROCI (R&D-adjusted, %): 4.736750235863556
Rosenberg metric: 0.6641991924629879
FCF margin (%): 19.108835385118205
Revenue growth (%): 12.639587679469875
Rule of 40 score: 31.74842306458808
Financial ratios for AMG.DE — quarterly report dated 2025-09-30
Total revenue: 9557000000
Gross profit: 6475000000
Operating income: 2526000000
Net income: 3216000000
Capital expenditures: 436000000
Operating cash flow: 4684000000
Depreciation & amortization: 1307000000
Net tangible assets: -32196000000
Owner earnings: 4087000000
Return on net tangible assets (%): -12.694123493601689
Capex to operating income (%): 17.26049089469517
Buffett classification: The Great
Stock price: 270.6
P/E ratio: 22.898253205456257
Shares outstanding: 539708274
Book value: 9619000000
P/B ratio: 15.182977330741242
Market cap (USD): 146045058944.40002
Debt to equity: 5.674914232248675
Current ratio: 1.2796567390206965
Quick ratio: 0.9884355926758753
Effective tax rate (%): 17.98010711553175
Interest coverage ratio: 3.6875912408759124
COGS to revenue (%): 32.24861358166789
R&D to revenue (%): 19.880715705765407
SG&A to revenue (%): 17.997279481008686
Free cash flow (dilution-adjusted): 4121000000
Buyback yield (%): 0
Retained earnings: -23800000000
Inventory turnover: 0.4856602584305074
Receivables turnover: 1.1256772673733804
Capitalized R&D asset: 3558860000
ROCI (R&D-adjusted, %): 3.7770032788727286
Rosenberg metric: 0.17603211009174313
FCF margin (%): 43.12022601234697
Revenue growth (%): 4.118095653121255
Rule of 40 score: 47.23832166546822
Financial ratios for AMG.DE — annual report dated 2025-12-31
Total revenue: 36751000000
Gross profit: 24714000000
Operating income: 9080000000
Net income: 7711000000
Capital expenditures: 1858000000
Operating cash flow: 9958000000
Depreciation & amortization: 5167000000
Net tangible assets: -32298000000
Owner earnings: 11020000000
Return on net tangible assets (%): -34.119759737445044
Capex to operating income (%): 20.462555066079297
Buffett classification: The Great
Stock price: 324.2235294117647
P/E ratio: 22.693051672806607
Shares outstanding: 539708274
Book value: 8658000000
P/B ratio: 20.210917238278096
Market cap (USD): 174986121449.01175
Debt to equity: 6.306768306768307
Current ratio: 1.1399819529993331
Quick ratio: 0.8957589548432657
Effective tax rate (%): 14.093137254901961
Interest coverage ratio: 3.2958257713248638
COGS to revenue (%): 32.75285026257789
R&D to revenue (%): 19.787216674376207
SG&A to revenue (%): 19.183151478871324
Free cash flow (dilution-adjusted): 7606000000
Buyback yield (%): 0
Retained earnings: -25107000000
Inventory turnover: 1.9336546184738956
Receivables turnover: 3.840229885057471
Capitalized R&D asset: 12846600000
ROCI (R&D-adjusted, %): 13.272845151280327
Rosenberg metric: 0.6955063715627096
FCF margin (%): 20.6960354820277
Revenue growth (%): 9.95392532312111
Rule of 40 score: 30.649960805148808
Financial ratios for AMG.DE — quarterly report dated 2025-12-31
Total revenue: 9866000000
Gross profit: 6890000000
Operating income: 2720000000
Net income: 1333000000
Capital expenditures: 642000000
Operating cash flow: 1603000000
Depreciation & amortization: 1132000000
Net tangible assets: -32298000000
Owner earnings: 1823000000
Return on net tangible assets (%): -5.644312341321444
Capex to operating income (%): 23.602941176470587
Buffett classification: The Great
Stock price: 324.2235294117647
P/E ratio: 22.693051672806607
Shares outstanding: 539708274
Book value: 8658000000
P/B ratio: 20.210917238278096
Market cap (USD): 174986121449.01175
Debt to equity: 6.306768306768307
Current ratio: 1.1399819529993331
Quick ratio: 0.8957589548432657
Effective tax rate (%): 11.955085865257596
Interest coverage ratio: 4.165390505359878
COGS to revenue (%): 30.164200283802963
R&D to revenue (%): 21.710926413946886
SG&A to revenue (%): 19.785120616257856
Free cash flow (dilution-adjusted): 836000000
Buyback yield (%): 0
Retained earnings: -25107000000
Inventory turnover: 0.47807228915662653
Receivables turnover: 1.0309299895506792
Capitalized R&D asset: 3990520000
ROCI (R&D-adjusted, %): 4.245822303844939
Rosenberg metric: 0.21842105263157896
FCF margin (%): 8.473545509831744
Revenue growth (%): 3.2332321858323745
Rule of 40 score: 11.706777695664119
Financial ratios for AMS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.37
Shares outstanding: 6625000
Market cap (USD): 15701250
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMS — annual report dated 2022-12-31
Total revenue: 19746000
Gross profit: 8382000
Operating income: 3237000
Net income: 1555000
Capital expenditures: 388000
Operating cash flow: 7235000
Depreciation & amortization: 4783000
Net tangible assets: 20282000
Owner earnings: 5950000
Return on net tangible assets (%): 29.336357361206982
Capex to operating income (%): 11.986407167130059
Buffett classification: The Great
Stock price: 2.93
P/E ratio: 12.483118971061094
Shares outstanding: 6625000
Book value: 25625000
P/B ratio: 0.7575121951219513
Market cap (USD): 19411250
Debt to equity: 0.5586341463414635
Current ratio: 3.6179710144927535
Quick ratio: 3.6179710144927535
Effective tax rate (%): 38.24463860206513
Interest coverage ratio: 4.016129032258065
COGS to revenue (%): 57.55089638407779
SG&A to revenue (%): 26.05591005773321
Free cash flow (dilution-adjusted): 6448000
Buyback yield (%): 0
Retained earnings: 3019000
Receivables turnover: 4.78343023255814
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.346870890384468
FCF margin (%): 32.65471487896283
Rule of 40 score: 32.65471487896283
Financial ratios for AMS — annual report dated 2023-12-31
Total revenue: 21325000
Gross profit: 9344000
Operating income: 2322000
Net income: 610000
Capital expenditures: 6273000
Operating cash flow: 5718000
Depreciation & amortization: 5165000
Net tangible assets: 21281000
Owner earnings: -498000
Return on net tangible assets (%): -2.3401155960716133
Capex to operating income (%): 270.1550387596899
Buffett classification: The Gruesome
Stock price: 2.38
P/E ratio: 25.848360655737704
Shares outstanding: 6625000
Book value: 26279000
P/B ratio: 0.6000038053198371
Market cap (USD): 15767500
Debt to equity: 0.6713725788652536
Current ratio: 1.8977641710733835
Quick ratio: 1.8977641710733835
Effective tax rate (%): 61.92528735632183
Interest coverage ratio: 2.088129496402878
COGS to revenue (%): 56.18288393903869
SG&A to revenue (%): 32.928487690504106
Free cash flow (dilution-adjusted): -944000
Buyback yield (%): 0
Retained earnings: 3629000
Receivables turnover: 4.399628636269858
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.211379504052644
FCF margin (%): -4.42672919109027
Revenue growth (%): 7.996556264559911
Rule of 40 score: 3.569827073469641
Financial ratios for AMS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.05
Shares outstanding: 6625000
Market cap (USD): 20206250
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMS — quarterly report dated 2024-12-31
Capital expenditures: 4660000
Buffett classification: The Gruesome
Stock price: 3.19
Shares outstanding: 6625000
Market cap (USD): 21133750
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMS — annual report dated 2024-12-31
Total revenue: 28340000
Gross profit: 9185000
Operating income: 1778000
Net income: 2186000
Capital expenditures: 7643000
Operating cash flow: 167000
Depreciation & amortization: 6174000
Net tangible assets: 23840000
Owner earnings: 717000
Return on net tangible assets (%): 3.00755033557047
Capex to operating income (%): 429.86501687289086
Buffett classification: The Gruesome
Stock price: 3.19
P/E ratio: 9.667772186642269
Shares outstanding: 6625000
Book value: 30027000
P/B ratio: 0.7038248909314949
Market cap (USD): 21133750
Debt to equity: 0.7735704532587339
Current ratio: 2.5235944257568477
Quick ratio: 2.5235944257568477
Effective tax rate (%): -23.848019401778497
Interest coverage ratio: 1.1861240827218145
COGS to revenue (%): 67.58997882851094
SG&A to revenue (%): 26.136203246294986
Free cash flow (dilution-adjusted): -8144000
Buyback yield (%): 0
Retained earnings: 5815000
Receivables turnover: 2.2380162678670144
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5708547557840613
FCF margin (%): -28.736767819336627
Revenue growth (%): 32.895662368112546
Rule of 40 score: 4.158894548775919
Financial ratios for AMS — quarterly report dated 2025-03-31
Total revenue: 6112000
Gross profit: 942000
Operating income: -866000
Net income: -625000
Capital expenditures: 4015000
Operating cash flow: 2503000
Depreciation & amortization: 1449000
Net tangible assets: 23304000
Owner earnings: -3191000
Return on net tangible assets (%): -13.692928252660488
Buffett classification: The Gruesome
Stock price: 2.78
Shares outstanding: 6625000
Book value: 29212000
P/B ratio: 0.6304772011502122
Market cap (USD): 18417500
Debt to equity: 0.9598795015746954
Current ratio: 1.8679779701022816
Quick ratio: 1.8679779701022816
Interest coverage ratio: -2
COGS to revenue (%): 84.58769633507853
SG&A to revenue (%): 29.581151832460733
Free cash flow (dilution-adjusted): -1601000
Buyback yield (%): 0
Retained earnings: 5190000
Receivables turnover: 0.5801063022019742
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.7114286278927293
FCF margin (%): -26.19437172774869
Rule of 40 score: -26.19437172774869
Financial ratios for AMS — quarterly report dated 2025-06-30
Total revenue: 7071000
Gross profit: 1630000
Operating income: -116000
Net income: -280000
Capital expenditures: 1901000
Operating cash flow: -372000
Depreciation & amortization: 1508000
Net tangible assets: 23138000
Owner earnings: -673000
Return on net tangible assets (%): -2.9086351456478523
Buffett classification: The Gruesome
Stock price: 2.41
Shares outstanding: 6625000
Book value: 28848000
P/B ratio: 0.5534612451469773
Market cap (USD): 15966250.000000002
Debt to equity: 0.9955282861896838
Current ratio: 1.1712847555129435
Quick ratio: 1.1712847555129435
Interest coverage ratio: -0.27102803738317754
COGS to revenue (%): 76.94809786451704
SG&A to revenue (%): 24.692405600339416
Free cash flow (dilution-adjusted): -2387000
Buyback yield (%): 0
Retained earnings: 4910000
Receivables turnover: 0.594651417038096
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.27208331378711825
FCF margin (%): -33.75760147079621
Revenue growth (%): 15.69044502617801
Rule of 40 score: -18.0671564446182
Financial ratios for AMS — quarterly report dated 2025-09-30
Total revenue: 7171000
Gross profit: 1586000
Operating income: 48000
Net income: -17000
Capital expenditures: 3702000
Operating cash flow: 1671000
Depreciation & amortization: 1454000
Net tangible assets: 23222000
Owner earnings: -2265000
Return on net tangible assets (%): -9.753681853414866
Capex to operating income (%): 7712.5
Buffett classification: The Gruesome
Stock price: 2.8
Shares outstanding: 6625000
Book value: 28599000
P/B ratio: 0.6486240777649568
Market cap (USD): 18550000
Debt to equity: 0.878946816322249
Current ratio: 1.199173024285132
Quick ratio: 1.199173024285132
Interest coverage ratio: 0.12244897959183673
COGS to revenue (%): 77.88314042671874
SG&A to revenue (%): 21.447496862362293
Free cash flow (dilution-adjusted): -2132000
Buyback yield (%): 0
Retained earnings: 4893000
Receivables turnover: 0.4905595840744288
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.11305289933581422
FCF margin (%): -29.73086040998466
Revenue growth (%): 1.4142271248762552
Rule of 40 score: -28.316633285108406
Financial ratios for AMS — annual report dated 2025-12-31
Total revenue: 28082000
Gross profit: 5064000
Operating income: -2014000
Net income: -1553000
Capital expenditures: 7634000
Operating cash flow: 3098000
Depreciation & amortization: 5714000
Net tangible assets: 22691000
Owner earnings: -3473000
Return on net tangible assets (%): -15.305627781939975
Buffett classification: The Gruesome
Stock price: 2.11
Shares outstanding: 6625000
Book value: 27691000
P/B ratio: 0.5048120327904373
Market cap (USD): 13978750
Debt to equity: 0.816510779675707
Current ratio: 0.7558437126770176
Quick ratio: 0.7558437126770176
Interest coverage ratio: -1.2795425667090217
COGS to revenue (%): 81.96709636065808
SG&A to revenue (%): 25.20475749590485
Free cash flow (dilution-adjusted): -4940000
Buyback yield (%): 0
Retained earnings: 4262000
Receivables turnover: 2.1238844350325214
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.286873731855783
FCF margin (%): -17.591339648173207
Revenue growth (%): -0.9103740296400847
Rule of 40 score: -18.501713677813292
Financial ratios for AMS — quarterly report dated 2025-12-31
Total revenue: 7728000
Gross profit: 906000
Operating income: -1080000
Net income: -631000
Capital expenditures: 1984000
Operating cash flow: -704000
Depreciation & amortization: 1303000
Net tangible assets: 22691000
Owner earnings: -1312000
Return on net tangible assets (%): -5.782028116874532
Buffett classification: The Gruesome
Stock price: 2.11
Shares outstanding: 6625000
Book value: 27691000
P/B ratio: 0.5048120327904373
Market cap (USD): 13978750
Debt to equity: 0.816510779675707
Current ratio: 0.7558437126770176
Quick ratio: 0.7558437126770176
Interest coverage ratio: -3.364485981308411
COGS to revenue (%): 88.27639751552795
SG&A to revenue (%): 25.698757763975156
Free cash flow (dilution-adjusted): 1180000
Buyback yield (%): 0
Retained earnings: 4262000
Receivables turnover: 0.5844804114354863
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.371312626814422
FCF margin (%): 15.269151138716355
Revenue growth (%): 7.767396457955655
Rule of 40 score: 23.03654759667201
Financial ratios for ARTV — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.45
Shares outstanding: 48588198
Market cap (USD): 750687659.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARTV — annual report dated 2024-12-31
Total revenue: 251000
Operating income: -67282000
Net income: -58179000
Capital expenditures: 642000
Operating cash flow: -55032000
Depreciation & amortization: 2431000
Net tangible assets: 186641000
Owner earnings: -56390000
Return on net tangible assets (%): -30.213082870323245
Buffett classification: The Gruesome
Stock price: 10.08
Shares outstanding: 48588198
Book value: 186641000
P/B ratio: 2.624123508982485
Market cap (USD): 489769035.84
Debt to equity: 0.07690700328438017
Current ratio: 15.394678854158165
Quick ratio: 15.394678854158165
COGS to revenue (%): 0
R&D to revenue (%): 20050.996015936256
SG&A to revenue (%): 6854.581673306772
Free cash flow (dilution-adjusted): -62654000
Buyback yield (%): 0.8540760427669261
Retained earnings: -246684000
Receivables turnover: 1.7191780821917808
Capitalized R&D asset: 98510890
ROCI (R&D-adjusted, %): -22.0193047190877
FCF margin (%): -24961.75298804781
Revenue growth (%): -89.57389228857076
Rule of 40 score: -25051.326880336383
Financial ratios for ARTV — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.08
Shares outstanding: 48588198
Market cap (USD): 489769035.84
Buyback yield (%): 0.8540760427669261
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARTV — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -22171000
Net income: -20311000
Capital expenditures: 511000
Operating cash flow: -19841000
Depreciation & amortization: 628000
Net tangible assets: 168783000
Owner earnings: -20194000
Return on net tangible assets (%): -11.964475095240633
Buffett classification: The Gruesome
Stock price: 3
Shares outstanding: 48588198
Book value: 168783000
P/B ratio: 0.8636213007234141
Market cap (USD): 145764594
Debt to equity: 0.08292304319747842
Current ratio: 13.930186823992134
Quick ratio: 13.930186823992134
Free cash flow (dilution-adjusted): -22404000
Buyback yield (%): 0
Retained earnings: -266995000
Receivables turnover: 0
Capitalized R&D asset: 17052000
ROCI (R&D-adjusted, %): -5.508615019045337
Rule of 40 score: 0
Financial ratios for ARTV — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -22810000
Net income: -21254000
Capital expenditures: 1055000
Operating cash flow: -22983000
Depreciation & amortization: 641000
Net tangible assets: 149041000
Owner earnings: -21668000
Return on net tangible assets (%): -14.53828141249723
Buffett classification: The Gruesome
Stock price: 1.51
Shares outstanding: 48588198
Book value: 149041000
P/B ratio: 0.4922684293583645
Market cap (USD): 73368178.98
Debt to equity: 0.08872726296790816
Current ratio: 13.843424962852897
Quick ratio: 13.843424962852897
Free cash flow (dilution-adjusted): -25587000
Buyback yield (%): 0
Retained earnings: -288249000
Receivables turnover: 0
Capitalized R&D asset: 29285840
ROCI (R&D-adjusted, %): -8.82697517938308
Rule of 40 score: 0
Financial ratios for ARTV — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -22897000
Net income: -21528000
Capital expenditures: 600000
Operating cash flow: -19201000
Depreciation & amortization: 662000
Net tangible assets: 129224000
Owner earnings: -21466000
Return on net tangible assets (%): -16.611465362471368
Buffett classification: The Gruesome
Stock price: 2.87
Shares outstanding: 48588198
Book value: 129224000
P/B ratio: 1.079119422553086
Market cap (USD): 139448128.26
Debt to equity: 0.09047081037578159
Current ratio: 11.64888928860509
Quick ratio: 11.64888928860509
Free cash flow (dilution-adjusted): -21432000
Buyback yield (%): 0
Retained earnings: -309777000
Receivables turnover: 0
Capitalized R&D asset: 35227030
ROCI (R&D-adjusted, %): -13.169526150474354
Rule of 40 score: 0
Financial ratios for ARTV — annual report dated 2025-12-31
Total revenue: 0
Operating income: -89810000
Net income: -83865000
Capital expenditures: 2587000
Operating cash flow: -76751000
Depreciation & amortization: 2597000
Net tangible assets: 109970000
Owner earnings: -83855000
Return on net tangible assets (%): -76.252614349368
Buffett classification: The Gruesome
Stock price: 4.29
Shares outstanding: 48588198
Book value: 109970000
P/B ratio: 1.8954566647267437
Market cap (USD): 208443369.42
Debt to equity: 0.09949986359916341
Current ratio: 8.609001298999006
Quick ratio: 8.609001298999006
Free cash flow (dilution-adjusted): -86159000
Buyback yield (%): 0
Retained earnings: -330549000
Receivables turnover: 0
Capitalized R&D asset: 119842590
ROCI (R&D-adjusted, %): -32.3844179579997
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for ARTV — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -21932000
Net income: -20772000
Capital expenditures: 421000
Operating cash flow: -14726000
Depreciation & amortization: 666000
Net tangible assets: 109970000
Owner earnings: -20527000
Return on net tangible assets (%): -18.665999818132217
Buffett classification: The Gruesome
Stock price: 4.29
Shares outstanding: 48588198
Book value: 109970000
P/B ratio: 1.8954566647267437
Market cap (USD): 208443369.42
Debt to equity: 0.09949986359916341
Current ratio: 8.609001298999006
Quick ratio: 8.609001298999006
Free cash flow (dilution-adjusted): -16736000
Buyback yield (%): 0
Retained earnings: -330549000
Receivables turnover: 0
Capitalized R&D asset: 34702240
ROCI (R&D-adjusted, %): -14.70549290866705
Rule of 40 score: 0
Financial ratios for BAX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 78.14
Shares outstanding: 516469008
Market cap (USD): 40356888285.12
Buyback yield (%): 1.4867350420107244
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BAX — annual report dated 2022-12-31
Total revenue: 10057000000
Gross profit: 3549000000
Operating income: -33000000
Net income: -2421000000
Capital expenditures: 635000000
Operating cash flow: 1211000000
Depreciation & amortization: 1072000000
Net tangible assets: -7412000000
Owner earnings: -1984000000
Buffett classification: The Gruesome
Stock price: 47.21
Shares outstanding: 516469008
Book value: 5895000000
P/B ratio: 4.136132632346056
Market cap (USD): 24382501867.68
Debt to equity: 2.9182357930449534
Current ratio: 1.6883034773445733
Quick ratio: 1.123709167544784
Interest coverage ratio: -0.07990314769975787
COGS to revenue (%): 64.71114646514864
R&D to revenue (%): 4.474495376354778
SG&A to revenue (%): 30.794471512379438
Free cash flow (dilution-adjusted): 436000000
Buyback yield (%): 0.1312416591769744
Retained earnings: 14050000000
Inventory turnover: 2.429264650989175
Receivables turnover: 3.834159359512009
Capitalized R&D asset: 450000000
ROCI (R&D-adjusted, %): 1.1128709569856619
FCF margin (%): 4.335288853534851
Rule of 40 score: 4.335288853534851
Financial ratios for BAX — annual report dated 2023-12-31
Total revenue: 10360000000
Gross profit: 4150000000
Operating income: 707000000
Net income: 2663000000
Capital expenditures: 436000000
Operating cash flow: 1726000000
Depreciation & amortization: 984000000
Net tangible assets: -3309000000
Owner earnings: 3211000000
Return on net tangible assets (%): -97.03838017527954
Capex to operating income (%): 61.669024045261665
Buffett classification: The Good
Stock price: 36.87
P/E ratio: 7.150661781809988
Shares outstanding: 516469008
Book value: 8468000000
P/B ratio: 2.248726065772319
Market cap (USD): 19042212324.96
Debt to equity: 1.6666273027869627
Current ratio: 1.4762417345840382
Quick ratio: 1.1813009380286021
Effective tax rate (%): 25.206611570247933
Interest coverage ratio: 1.391732283464567
COGS to revenue (%): 59.94208494208494
R&D to revenue (%): 5
SG&A to revenue (%): 38.011583011583014
Free cash flow (dilution-adjusted): 1175000000
Buyback yield (%): 0
Retained earnings: 16114000000
Inventory turnover: 3.237747653806048
Receivables turnover: 5.846501128668171
Capitalized R&D asset: 819500000
ROCI (R&D-adjusted, %): 3.9939507948803064
Rosenberg metric: 1.3355555555555556
FCF margin (%): 11.341698841698841
Revenue growth (%): 3.0128268867455503
Rule of 40 score: 14.354525728444392
Financial ratios for BAX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.07
Shares outstanding: 516469008
Market cap (USD): 19145506126.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BAX — annual report dated 2024-12-31
Total revenue: 10636000000
Gross profit: 3984000000
Operating income: 439000000
Net income: -638000000
Capital expenditures: 460000000
Operating cash flow: 1019000000
Depreciation & amortization: 997000000
Net tangible assets: -3534000000
Owner earnings: -101000000
Capex to operating income (%): 104.78359908883827
Buffett classification: The Gruesome
Stock price: 28.61
Shares outstanding: 516469008
Book value: 7024000000
P/B ratio: 2.1036700340091117
Market cap (USD): 14776178318.88
Debt to equity: 1.9147209567198178
Current ratio: 1.359698970972201
Quick ratio: 1.0454615266472125
Interest coverage ratio: 1.0759803921568627
COGS to revenue (%): 62.54230913877398
R&D to revenue (%): 5.547198194810079
SG&A to revenue (%): 27.895825498307637
Free cash flow (dilution-adjusted): 445000000
Buyback yield (%): 0
Retained earnings: 14929000000
Inventory turnover: 3.251221896383187
Receivables turnover: 6.147976878612717
Capitalized R&D asset: 1085560000
ROCI (R&D-adjusted, %): 2.503697415804373
Rosenberg metric: -0.3204633204633205
FCF margin (%): 4.183903723204212
Revenue growth (%): 2.664092664092664
Rule of 40 score: 6.847996387296876
Financial ratios for BAX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.61
Shares outstanding: 516469008
Market cap (USD): 14776178318.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BAX — quarterly report dated 2025-03-31
Total revenue: 2625000000
Gross profit: 861000000
Operating income: 58000000
Net income: 126000000
Capital expenditures: 122000000
Operating cash flow: -193000000
Depreciation & amortization: 247000000
Net tangible assets: -3338000000
Owner earnings: 251000000
Return on net tangible assets (%): -7.519472738166567
Capex to operating income (%): 210.3448275862069
Buffett classification: The Gruesome
Stock price: 33.75
P/E ratio: 34.58497821428571
Shares outstanding: 516469008
Book value: 7054000000
P/B ratio: 2.471055999432946
Market cap (USD): 17430829020
Debt to equity: 1.461440317550326
Current ratio: 2.0209709853490376
Quick ratio: 1.397586900316001
Interest coverage ratio: 0.7160493827160493
COGS to revenue (%): 67.2
R&D to revenue (%): 5.333333333333334
SG&A to revenue (%): 26.78095238095238
Free cash flow (dilution-adjusted): -325000000
Buyback yield (%): 0
Retained earnings: 14968000000
Inventory turnover: 0.8129032258064516
Receivables turnover: 1.594775212636695
Capitalized R&D asset: 140000000
ROCI (R&D-adjusted, %): 0.8424724897474438
FCF margin (%): -12.380952380952381
Rule of 40 score: -12.380952380952381
Financial ratios for BAX — quarterly report dated 2025-06-30
Total revenue: 2810000000
Gross profit: 991000000
Operating income: 191000000
Net income: 91000000
Capital expenditures: 149000000
Operating cash flow: 217000000
Depreciation & amortization: 257000000
Net tangible assets: -3025000000
Owner earnings: 199000000
Return on net tangible assets (%): -6.578512396694215
Capex to operating income (%): 78.01047120418848
Buffett classification: The Gruesome
Stock price: 30.02
P/E ratio: 71.44884617585254
Shares outstanding: 516469008
Book value: 7293000000
P/B ratio: 2.125928920904977
Market cap (USD): 15504399620.16
Debt to equity: 1.33347045111751
Current ratio: 2.296359305886356
Quick ratio: 1.4851990472949983
Effective tax rate (%): 8.270676691729323
Interest coverage ratio: 2.6527777777777777
COGS to revenue (%): 64.73309608540924
R&D to revenue (%): 4.7686832740213525
SG&A to revenue (%): 25.551601423487547
Free cash flow (dilution-adjusted): 33000000
Buyback yield (%): 0
Retained earnings: 14970000000
Inventory turnover: 0.763003355704698
Receivables turnover: 1.5848843767625493
Capitalized R&D asset: 227800000
ROCI (R&D-adjusted, %): 1.2744434990655296
Rosenberg metric: 0.9285714285714286
FCF margin (%): 1.1743772241992882
Revenue growth (%): 7.0476190476190474
Rule of 40 score: 8.221996271818336
Financial ratios for BAX — quarterly report dated 2025-09-30
Total revenue: 2835000000
Gross profit: 950000000
Operating income: 172000000
Net income: -46000000
Capital expenditures: 111000000
Operating cash flow: 237000000
Depreciation & amortization: 237000000
Net tangible assets: -2964000000
Owner earnings: 80000000
Capex to operating income (%): 64.53488372093024
Buffett classification: The Good
Stock price: 22.73
P/E ratio: 68.65111433824562
Shares outstanding: 516469008
Book value: 7214000000
P/B ratio: 1.62729977153313
Market cap (USD): 11739340551.84
Debt to equity: 1.3462711394510674
Current ratio: 1.8365562913907285
Quick ratio: 1.1849006622516556
Effective tax rate (%): 142.1487603305785
Interest coverage ratio: 2.5294117647058822
COGS to revenue (%): 66.49029982363317
R&D to revenue (%): 4.162257495590829
SG&A to revenue (%): 24.97354497354497
Free cash flow (dilution-adjusted): 91000000
Buyback yield (%): 0
Retained earnings: 14837000000
Inventory turnover: 0.766260162601626
Receivables turnover: 1.5953854811480022
Capitalized R&D asset: 253980000
ROCI (R&D-adjusted, %): 0.908090248212601
Rosenberg metric: -0.30597014925373134
FCF margin (%): 3.2098765432098766
Revenue growth (%): 0.8896797153024912
Rule of 40 score: 4.099556258512368
Financial ratios for BAX — annual report dated 2025-12-31
Total revenue: 11244000000
Gross profit: 3379000000
Operating income: 177000000
Net income: -957000000
Capital expenditures: 522000000
Operating cash flow: 845000000
Depreciation & amortization: 981000000
Net tangible assets: -3169000000
Owner earnings: -498000000
Capex to operating income (%): 294.91525423728814
Buffett classification: The Gruesome
Stock price: 19.09
Shares outstanding: 516469008
Book value: 6102000000
P/B ratio: 1.6157642351229105
Market cap (USD): 9859393362.72
Debt to equity: 1.6027531956735497
Current ratio: 2.3138047138047138
Quick ratio: 1.5622895622895623
Interest coverage ratio: 0.6103448275862069
COGS to revenue (%): 69.94841693347563
R&D to revenue (%): 4.606901458555674
SG&A to revenue (%): 25.70259694059054
Free cash flow (dilution-adjusted): 206000000
Buyback yield (%): 0
Retained earnings: 13705000000
Inventory turnover: 3.5237455197132617
Receivables turnover: 5.819875776397516
Capitalized R&D asset: 1084240000
ROCI (R&D-adjusted, %): 0.8420825527099647
Rosenberg metric: -1.0254237288135593
FCF margin (%): 1.8320882248310209
Revenue growth (%): 5.7164347499059796
Rule of 40 score: 7.548522974737001
Financial ratios for BAX — quarterly report dated 2025-12-31
Total revenue: 2974000000
Gross profit: 577000000
Operating income: -244000000
Net income: -1128000000
Capital expenditures: 140000000
Operating cash flow: 584000000
Depreciation & amortization: 240000000
Net tangible assets: -3169000000
Owner earnings: -1028000000
Buffett classification: The Gruesome
Stock price: 19.09
Shares outstanding: 516469008
Book value: 6102000000
P/B ratio: 1.6157642351229105
Market cap (USD): 9859393362.72
Debt to equity: 1.6027531956735497
Current ratio: 2.3138047138047138
Quick ratio: 1.5622895622895623
Interest coverage ratio: -3.536231884057971
COGS to revenue (%): 80.59852051109617
R&D to revenue (%): 4.236718224613315
SG&A to revenue (%): 25.58843308675185
Free cash flow (dilution-adjusted): 407000000
Buyback yield (%): 0
Retained earnings: 13705000000
Inventory turnover: 1.0739247311827957
Receivables turnover: 1.5393374741200827
Capitalized R&D asset: 249280000
ROCI (R&D-adjusted, %): -1.4076154302341948
Rosenberg metric: -3.1610169491525424
FCF margin (%): 13.685272360457295
Revenue growth (%): 4.90299823633157
Rule of 40 score: 18.588270596788867
Financial ratios for BEKE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.67
Shares outstanding: 1060290096
Market cap (USD): 19795616092.320004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BEKE — annual report dated 2022-12-31
Total revenue: 8716778591.954023
Gross profit: 1979992385.0574713
Operating income: -2367385.057471264
Net income: -199148563.2183908
Capital expenditures: 113941379.31034483
Operating cash flow: 1223971695.402299
Depreciation & amortization: 215908189.6551724
Net tangible assets: 8938787500
Owner earnings: -97181752.87356322
Return on net tangible assets (%): -1.0871916674779798
Buffett classification: The Gruesome
Stock price: 12.96
Shares outstanding: 1060290096
Book value: 9921614655.172413
P/B ratio: 1.384992274115005
Market cap (USD): 13741359644.160002
Debt to equity: 0.176545857921543
Current ratio: 2.1122342853992757
Quick ratio: 2.1084084618370516
Effective tax rate (%): 578.0471449587739
Interest coverage ratio: -1.1374430484605826
COGS to revenue (%): 77.28527386384354
R&D to revenue (%): 4.195813797406406
SG&A to revenue (%): 19.647745012306906
Free cash flow (dilution-adjusted): 761575000
Buyback yield (%): 1.3799643338026992
Retained earnings: -1638771551.724138
Inventory turnover: 367.58205678985246
Receivables turnover: 10.1250949194599
Capitalized R&D asset: 365739798.85057473
ROCI (R&D-adjusted, %): 2.1394295435626596
FCF margin (%): 8.736885903044133
Rule of 40 score: 8.736885903044133
Financial ratios for BEKE — annual report dated 2023-12-31
Total revenue: 10939090295.35865
Gross profit: 3054572995.7805905
Operating income: 795015049.2264416
Net income: 828354992.9676511
Capital expenditures: 122924050.63291138
Operating cash flow: 1605378902.9535863
Depreciation & amortization: 197213502.10970464
Net tangible assets: 9273943881.856539
Owner earnings: 902644444.4444444
Return on net tangible assets (%): 9.733123856942568
Capex to operating income (%): 15.461852043243438
Buffett classification: The Great
Stock price: 15.21
P/E ratio: 19.468721136554787
Shares outstanding: 1060290096
Book value: 10154867088.607594
P/B ratio: 1.5881066900671066
Market cap (USD): 16127012360.160002
Debt to equity: 0.24911211538936973
Current ratio: 1.7648429562374823
Quick ratio: 1.7571461611042591
Effective tax rate (%): 25.296705540782305
Interest coverage ratio: 296.17799318836785
COGS to revenue (%): 72.07653549512597
R&D to revenue (%): 2.490172793136145
SG&A to revenue (%): 19.145454335997723
Free cash flow (dilution-adjusted): 1030197609.0014064
Buyback yield (%): 4.4919681152732105
Retained earnings: -797878481.0126582
Inventory turnover: 184.27825040761581
Receivables turnover: 13.43593949822785
Capitalized R&D asset: 517447915.58150256
ROCI (R&D-adjusted, %): 7.19275172587565
Rosenberg metric: 2.9381013882007023
FCF margin (%): 9.417580266601412
Revenue growth (%): 25.494644379930907
Rule of 40 score: 34.91222464653232
Financial ratios for BEKE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.15
Shares outstanding: 1060290096
Market cap (USD): 20304555338.399998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BEKE — annual report dated 2024-12-31
Total revenue: 12802396986.30137
Gross profit: 3143021232.8767123
Operating income: 636676849.3150685
Net income: 558654794.520548
Capital expenditures: 142079315.06849316
Operating cash flow: 1294128356.1643836
Depreciation & amortization: 138686575.34246576
Net tangible assets: 8944749863.013699
Owner earnings: 555262054.7945206
Return on net tangible assets (%): 6.2076867804935985
Capex to operating income (%): 22.315765874217174
Buffett classification: The Great
Stock price: 17.71
P/E ratio: 33.61241644095356
Shares outstanding: 1060290096
Book value: 9787396575.342464
P/B ratio: 1.9185630678813033
Market cap (USD): 18777737600.16
Debt to equity: 0.31708029035664337
Current ratio: 1.4523542069735818
Quick ratio: 1.4218319082240192
Effective tax rate (%): 40.638441913756616
Interest coverage ratio: 334.3458024602546
COGS to revenue (%): 75.44974401090857
R&D to revenue (%): 2.443275337843947
SG&A to revenue (%): 17.916259645641276
Free cash flow (dilution-adjusted): 778614109.5890412
Buyback yield (%): 3.721319383199506
Retained earnings: -236148082.19178084
Inventory turnover: 43.80054302318936
Receivables turnover: 9.901214885952347
Capitalized R&D asset: 616001449.5754514
ROCI (R&D-adjusted, %): 5.438293901770035
Rosenberg metric: 0.3246971601077179
FCF margin (%): 6.081783828623361
Revenue growth (%): 17.033470248740002
Rule of 40 score: 23.115254077363364
Financial ratios for BEKE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.71
Shares outstanding: 1060290096
Market cap (USD): 18777737600.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BEKE — quarterly report dated 2025-03-31
Total revenue: 3213270936.6391187
Gross profit: 664034710.7438017
Operating income: 81345041.32231405
Net income: 117874242.42424242
Capital expenditures: 0
Operating cash flow: -546180578.5123967
Net tangible assets: 8709527823.69146
Owner earnings: 117874242.42424242
Return on net tangible assets (%): 1.3533941771631246
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 19.32
P/E ratio: 43.44631242887001
Shares outstanding: 1060290096
Book value: 9497429614.325071
P/B ratio: 2.1568788068534412
Market cap (USD): 20484804654.72
Debt to equity: 0.32400488988328413
Current ratio: 1.3298588914860607
Quick ratio: 1.3298588914860607
Effective tax rate (%): 38.144590093276
COGS to revenue (%): 79.3346180936009
R&D to revenue (%): 2.5017203319206454
SG&A to revenue (%): 15.632127728552733
Free cash flow (dilution-adjusted): -546180578.5123967
Buyback yield (%): 0
Retained earnings: -119574931.12947659
Receivables turnover: 1.5177605531519933
Capitalized R&D asset: 80387052.3415978
ROCI (R&D-adjusted, %): 1.2489905524922666
FCF margin (%): -16.997650969440738
Rule of 40 score: -16.997650969440738
Financial ratios for BEKE — quarterly report dated 2025-06-30
Total revenue: 3627703765.6903768
Gross profit: 794949790.7949791
Operating income: 197177545.32775453
Net income: 182237656.90376568
Capital expenditures: 0
Operating cash flow: 115231938.63319387
Net tangible assets: 8756965969.316597
Owner earnings: 182237656.90376568
Return on net tangible assets (%): 2.0810593251396146
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 17.42
P/E ratio: 61.54455559302195
Shares outstanding: 1060290096
Book value: 9601071687.58717
P/B ratio: 1.9237699783243398
Market cap (USD): 18470253472.320004
Debt to equity: 0.3191475428620503
Current ratio: 1.4820907867698954
Quick ratio: 1.4253824067782486
Effective tax rate (%): 23.94968718916078
COGS to revenue (%): 78.086694996616
R&D to revenue (%): 2.4353191517500763
SG&A to revenue (%): 15.296438733754913
Free cash flow (dilution-adjusted): 47959135.28591353
Buyback yield (%): 0
Retained earnings: 60384518.82845189
Inventory turnover: 7.8341792043027185
Receivables turnover: 3.320744686555411
Capitalized R&D asset: 142205489.64348698
ROCI (R&D-adjusted, %): 2.081120943849236
Rosenberg metric: 1.6285592796071826
FCF margin (%): 1.3220245748700645
Revenue growth (%): 12.897537656277718
Rule of 40 score: 14.219562231147783